Speech by Federal Chancellor Dr. Angela Merkel at the celebration of the 350th anniversary of the company Merck on May 3, 2018, in Darmstadt:

Germany Angela Merkel · Former Chancellor of Germany

4 May 2018 · Celebration of the 350th anniversary of the company Merck · Darmstadt, Germany

Context
Merkel addressed guests and employees at Merck's 350th anniversary celebration in Darmstadt on May 3, 2018, also marking the opening of the new Innovation Center.
Main themes
Corporate anniversary, innovation and research, social market economy, family ownership, German industrial history, forced labor and historical responsibility, liquid crystal technology, pharmaceutical development, curiosity and future orientation, Made in Germany
Duration
~15 min
52nd percentile
Words
1,812
52nd percentile
Sentences
112
68th percentile
Readability
43
43rd percentile
Grade
11.3
36th percentile
Syntax
2.80
22nd percentile
Vocabulary
2.14
35th percentile

Translated from German

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Economic 33%33%
  • Social 27%27%
  • Ceremonial 22%22%
  • Technological 8%8%
  • Geopolitical 4%4%
  • Institutional 4%4%
  • Environmental 1%1%
  • Not in focus 0%

112 sentences in 25 paragraphs

Dear Mr. Spangenberg-Haverkamp,

dear Mr. Oschmann,

dear Minister-President, dear Volker Bouffier,

dear Mayor Partsch,

Excellency,

ladies and gentlemen,

and above all: dear employees of Merck, who are following this event from various locations,

350 years is a proud number. It is not easy for us today to imagine the time back then. Much is being said these days about the 400th anniversary of the beginning of the Thirty Years' War, which ended with a devastated Europe, a devastated Germany. Only 20 years after the end of this war, the history of the company began, which ultimately became a century-long corporate history. Conversely, it was even less imaginable back then that the company could become a large and globally active corporation. Even as a corporation, the company is still in the hands of the founding family. I can only speculate what has driven you as a family tirelessly for generations. However, it seems that the Merck family is richly blessed with knowledge, will, and ability. That is precisely what makes this traditional company a good piece of lived social market economy, which not only the state of Hesse is proud of, but the Federal Republic of Germany as a whole.

That is why I am very pleased to be here with you again – I say "again," because I was here in 2010 for the opening of the Materials Research Center. Today I am here for the opening of the new Innovation Center, which brings together experts and start-ups and consolidates various competencies. Research and innovation have always distinguished Merck. Consequently, your anniversary is under the motto – which would probably have been somewhat different at the beginning; back then, German and English were not mixed so much –: "Imagine. Always curious – even in the next 350 years"; "Celebrate Curiosity." It would be interesting to hear in which language we will celebrate in 350 years. But do not forget the German.

Curiosity and future orientation have guided your company from the very beginning. 350 years ago, the trained pharmacist Friedrich Jacob Merck set out to build a future as an independent pharmacist. His path led him to Darmstadt, where he acquired a pharmacy – the later Engel Pharmacy, which still exists today. However, the curiosity for new things never left him, nor did it leave his heirs later. They researched. They repeatedly created new medications from plant-based natural substances. They developed purity standards. They were concerned with binding quality that customers and patients could rely on. This is also something like the cornerstone of what we now call "Made in Germany." The concept thus became a recipe for success. Ultimately, in 1850, a joint venture was established that produced far beyond its own needs. This was essentially the beginning of industrial production.

The company has, of course, experienced highs and lows over the course of time. A bitter consequence of the war for Merck was the expropriation of the US subsidiary in 1917, which became independent and was never to be part of the German company again. The company history also includes the fact that during World War II, numerous forced laborers were employed to keep production running under terrible conditions. It remains our collective duty – and this duty has been embraced by Merck – to continually remember the suffering inflicted on forced laborers in Germany during National Socialism. The many initiatives that have kept the memory of this dark chapter of German history alive are of utmost importance. I would like to mention the Foundation "Remembrance, Responsibility and Future" here. It is essential that Merck has taken on this responsibility and, for example, operates the pharmacy project in Belarus to provide free access to medicines, as it also reflects the awareness of our ongoing responsibility for the horrors of the Holocaust and World War II.

Merck has achieved many successes in its long history: from the isolation of active ingredients to the development and production of highly complex medications that ease, improve, or even sustain life. When Merck began liquid crystal research in 1968, no one knew where the journey would lead; that is how it is in research. Other companies did not show as much perseverance as the Darmstadt researchers. However, their persistence truly paid off, as today no modern monitor or flat screen can do without liquid crystals. Merck is the undisputed world market leader in LC technology, for which completely new application areas are continually being found. I mention, for example, the so-called smart windows in buildings. With them, light transmission can be controlled and energy efficiency increased.

Progressive developments that are felt by everyone – this is the principle under which 52,000 Merck employees work and research in 66 countries worldwide, many of whom are listening here today. A heartfelt thank you from the federal government goes out to them. Merck has repeatedly demonstrated that research and development know no boundaries. This is equally true for a large part of the German research landscape. We have a real trump card with our pharmaceutical and biotechnology industry, as health and healthcare are issues that concern us all worldwide.

Of course, good international and interdisciplinary collaboration in the research and development of new means and methods is also crucial. In this regard, industrialized countries like Germany bear special responsibility, as we have many research opportunities that poorer countries lack. During our G20 presidency last year, we made significant progress in the international health sector. I would like to sincerely thank Merck for its continued participation in these activities.

We are also utilizing our opportunities at home. Since 2009, the federal government has established six German Centers for Health Research. We want to shape Germany as a location for health research with a forward-looking approach, with concrete initiatives: for example, with the E-Health Initiative to better utilize digital applications, or with our strategy process to further advance innovations in medical technology.

Mr. Oschmann has just pointed out the diverse challenges we face. The merging of digitalization and classical development and the development of artificial intelligence will present us with many challenges. I would like to express my heartfelt thanks that here at Merck, not only is technical research being conducted, but the ethical component is always kept in mind. Because only if those who possess the technical know-how also accompany the ethical discussion will we truly make progress and be able to develop responsible products.

We will also continue the pharmaceutical dialogue between politics, science, and industry, as the challenges will not diminish. Rather, the supply of high-quality and affordable medicines is a permanent task. Of course, we Germans are proud to be a pharmaceutical location. But sometimes it is overlooked how tough the competition, how fierce the rivalry is. Therefore, it is about finding appropriate solutions for patients and insured individuals, but also with an eye on the future viability of the research location. This includes, for example, improving the physician information system. In addition, the security against counterfeiting and the safety of therapies for medicines must be further advanced.

There is also always a certain tension between EU regulations and national expectations. There are currently many discussions about this. Mr. Oschmann has pointed out that the Minister-President of the state always keeps a close eye on what is happening in Brussels. We are trying to do the same at the federal level, as we believe that we can regulate some things well at the national level and that not everything needs to be regulated in Europe.

Your anniversary motto "Imagine. Always curious" also shows: despite all the digitalization and automation – the future viability of a company still depends on people and their curiosity. This human trait seems to be a constant at Merck over the 350 years. One does not need much foresight to say: This will also be essential for Merck and all others in the next 350 years.

Perhaps the fact that Darmstadt is the constant home location of Merck plays a role here. Darmstadt has gradually developed into a city of science. In addition to the Technical University and the two colleges, there are numerous institutes and research companies here – including and especially Merck – where concentrated knowledge, experience, and promising young talents can be found.

We all know: It is not enough to rest on what has been achieved. We face enormous challenges that apply to everyone working in such a company. Lifelong learning, further education, and part-time qualification – all of this is crucial to keep our location innovative and thus competitive. But it is also about each individual maintaining good career prospects throughout their life.

Learning also depends on motivation. That is why we are politically committed to continually focusing on opportunities for professional change and advancement. Therefore, we want to develop a National Continuing Education Strategy in the federal government. In this regard, the federal and state governments want to work very closely together. We want to give all employees a right to continuing education counseling so that they can better orient themselves. Of course, it is important to have as many company-specific offerings as possible. I am sure that Merck can also say a lot about this and that we can learn a lot from Merck when it comes to how to organize technological change. As the Minister-President has already said: If the last strike was in 1971, then there must be a good social partnership here that can also guarantee that we can navigate through technically revolutionary times well.

Of course, the organization of work will also change. Questions of flexibility play a prominent role in this. What will good, safe, and healthy work look like in the future? How can working hours be arranged so that they meet the needs of employees, employers, and families alike? All of this presents significant challenges. I believe that Merck will solve them well.

All good things are known to come in threes. In the case of Merck, these are Healthcare, Life Science, and Performance Materials. Whatever questions may arise in the future – Merck will always work to anticipate the answers. Committed to innovation and connected to tradition – this family business has created real value for many, many people over generations; both within the company and outside of it. You do not only think of today, but always also of tomorrow and the day after tomorrow – true to your anniversary motto: "Imagine. Always curious – even in the next 350 years." While we may have difficulty keeping track of whether you will maintain your curiosity for centuries to come; that is not granted to those present today. However, we may accompany you with a good measure of healthy optimism. Your foresight nourishes the confidence in future successes. I wish you this from the bottom of my heart.

Thank you for allowing me to be here today.